N-(2-amino-5-nitrophenyl)propionamide | 88374-33-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-amino-5-nitrophenyl)propionamide
• 英文别名: N-(2-Amino-5-nitrophenyl)propanamide
• CAS: 88374-33-8
• 化学式: C₉H₁₁N₃O₃
• 分子量: 209.205
• InChiKey: QJOMQCRVIPAJAL-UHFFFAOYSA-N

物化性质

• 熔点：
  190-191 °C
• 沸点：
  466.8±35.0 °C(Predicted)
• 密度：
  1.366±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  101
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-(2-amino-5-nitrophenyl)propionamide 在 盐酸 作用下， 以 乙醇 、 水 为溶剂， 生成 (9ci)-2-乙基-5-硝基-1H-苯并咪唑
  参考文献：
  名称：

  Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities

  摘要：

  The design, synthesis, in vitro and in vivo evaluation of 5-nitro benzimidazole with 1,4-disubsituted or 1,5-disubsituted indole derivatives as novel angiotensin II receptor antagonist is outlined. Radioligand binding assays showed that 2-(4-((2-butyl-5-nitro-1H-benzo[d] imidazol-1-yl) methyl)-1H-indol-1-yl) benzoic acid, compound 3, displayed a high affinity for the angiotensin II type 1 receptor with IC50 value of 1.03 +/- 0.26 nM. The biological evaluation on spontaneously hypertensive rats and renal hypertensive rats showed that 3 could cause significant decrease on MBP in a dose dependent manner, whose maximal response lowered 30 mmHg of MBP at 5 mg/kg and 41 mmHg of MBP at 10 mg/kg after oral administration, and the significant antihypertensive effect lasted beyond 24 h, which is better than Losartan. Taken together 3 could be considered as an effective and durable anti-hypertension drug candidate. These encouraging results are deserved of further investigation towards its use for therapeutic benefit. (c) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2014.02.008
• 作为产物：
  描述：

  丙酰氯 、 4-硝基邻苯二胺 在 三乙胺 作用下， 以 四氢呋喃 为溶剂， 以84%的产率得到N-(2-amino-5-nitrophenyl)propionamide
  参考文献：
  名称：

  Benzotriazole-Assisted Thioacylation

  摘要：

  Benzotriazole reagents for thioacylation (RCSBt), thiocarbamoylation (RR'NCSBt), aryl/alkoxythioacylation (ROCSBt), and aryl/alkylthiothioacylation (RSCSBt) are synthesized, and their utility is assessed by syntheses of representative heteroaryl thioureas 3a-g, thioamides 15a-s, thionoesters 16a-h, thiocarbamates 17a-e, dithiocarbamates 18a-d, thiocarbonates 19a-c, and dithiocarbonates 20a-c.

  DOI：

  10.1021/jo050670t

文献信息

• Benzotriazole-Assisted Thioacylation
  作者：Alan R. Katritzky、Rachel M. Witek、Valerie Rodriguez-Garcia、Prabhu P. Mohapatra、James W. Rogers、Janet Cusido、Ashraf A. A. Abdel-Fattah、Peter J. Steel

  DOI：10.1021/jo050670t

  日期：2005.9.1

  Benzotriazole reagents for thioacylation (RCSBt), thiocarbamoylation (RR'NCSBt), aryl/alkoxythioacylation (ROCSBt), and aryl/alkylthiothioacylation (RSCSBt) are synthesized, and their utility is assessed by syntheses of representative heteroaryl thioureas 3a-g, thioamides 15a-s, thionoesters 16a-h, thiocarbamates 17a-e, dithiocarbamates 18a-d, thiocarbonates 19a-c, and dithiocarbonates 20a-c.
• A General and Efficient Route to Thionoesters via Thionoacyl Nitrobenzotriazoles
  作者：M. Ashraf Shalaby、Henry Rapoport

  DOI：10.1021/jo981985u

  日期：1999.2.1
• Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities
  作者：Weibo Zhu、Yajing Da、Dan Wu、Huiling Zheng、Linfeng Zhu、Li Wang、Yijia Yan、Zhilong Chen

  DOI：10.1016/j.bmc.2014.02.008

  日期：2014.4

  The design, synthesis, in vitro and in vivo evaluation of 5-nitro benzimidazole with 1,4-disubsituted or 1,5-disubsituted indole derivatives as novel angiotensin II receptor antagonist is outlined. Radioligand binding assays showed that 2-(4-((2-butyl-5-nitro-1H-benzo[d] imidazol-1-yl) methyl)-1H-indol-1-yl) benzoic acid, compound 3, displayed a high affinity for the angiotensin II type 1 receptor with IC50 value of 1.03 +/- 0.26 nM. The biological evaluation on spontaneously hypertensive rats and renal hypertensive rats showed that 3 could cause significant decrease on MBP in a dose dependent manner, whose maximal response lowered 30 mmHg of MBP at 5 mg/kg and 41 mmHg of MBP at 10 mg/kg after oral administration, and the significant antihypertensive effect lasted beyond 24 h, which is better than Losartan. Taken together 3 could be considered as an effective and durable anti-hypertension drug candidate. These encouraging results are deserved of further investigation towards its use for therapeutic benefit. (c) 2014 Elsevier Ltd. All rights reserved.